Try our beta test site
72 studies found for:    Open Studies | "Bone Diseases, Infectious"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Bone Diseases, Infectious" (72 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery
Condition: Bone Diseases, Infectious
Intervention: Drug: Debio 1450
2 Recruiting Pressure Ulcer-associated Osteomyelitis: Evaluation of a Two-stage Surgical Strategy With Prolonged Antimicrobial Therapy
Condition: Bone Diseases, Infectious
Intervention:
3 Recruiting Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections
Conditions: Arthritis, Infectious;   Bone Diseases, Infectious
Intervention: Drug: usual antibiotic treatment
4 Recruiting UNiD 3D VBR Register
Conditions: Spinal Cord Compression;   Spondylosis;   Ossification of Posterior Longitudinal Ligament;   Spinal Neoplasms;   Bone Disease, Infectious
Intervention: Device: UNiD 3D VBR
5 Recruiting Fosfomycin i.v. for Treatment of Severely Infected Patients
Conditions: Bacterial Infections;   Bone Diseases, Infectious;   Osteomyelitis;   Central Nervous System Bacterial Infections;   Meningitis, Bacterial;   Encephalitis;   Brain Abscess;   Urinary Tract Infections;   Respiratory Tract Infections;   Pneumonia, Bacterial;   Skin Diseases, Bacterial;   Soft Tissue Infections;   Intraabdominal Infections;   Sepsis;   Bacteremia;   Endocarditis, Bacterial
Intervention:
6 Recruiting Chronic Non-bacterial Osteomyelitis Treated With Pamidronate
Conditions: Immune System Disease;   Musculoskeletal Disease
Interventions: Drug: Pamidronatdinatrium;   Other: Natrium chloride 9mg/ml
7 Recruiting CPP Bone Infection Registry
Conditions: Bone Infection;   Staphylococcus Aureus
Intervention:
8 Not yet recruiting Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
Conditions: Osteomyelitis;   Diabetes;   Amputation
Interventions: Drug: Rifampin;   Drug: Riboflavin Placebo
9 Recruiting A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis
Conditions: Spondylitis;   Spondylitis, Ankylosing;   Ankylosis;   Arthritis;   Spondylarthritis;   Spondylarthropathies;   Spinal Diseases;   Musculoskeletal Diseases;   Bone Diseases
Interventions: Biological: Intravenous infusion of MSCs;   Drug: Etanercept
10 Recruiting Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Subjects With Osteomyelitis
Condition: Osteomyelitis
Interventions: Drug: Dalbavancin;   Drug: Comparator
11 Recruiting Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
Conditions: Hematogenously Acquired Staphylococcus Aureus Osteomyelitis;   Bone Infection;   Osteomyelitis
Intervention: Drug: Ceftaroline Fosamil
12 Recruiting CERAMENT™|G - Bone Healing and Re-infection Prophylaxis
Condition: Osteomyelitis
Intervention: Device: Cerament G
13 Not yet recruiting Patients Response to Early Switch To Oral:Osteomyelitis Study
Condition: Osteomyelitis
Interventions: Drug: oral antibiotics;   Procedure: intravenous antibiotics
14 Recruiting Application of DCE-MRI in the Diagnosis of Brucellar Spondylitis
Condition: Brucella Spondylitis
Intervention:
15 Recruiting Regional and Seasonal Variations in the Incidence and Causative Organisms for Post-traumatic Wound Infections and Osteomyelitis After Open Fractures
Condition: Infection
Intervention: Other: Infection
16 Recruiting Cytokine Profiles in Spondylodiscitis
Condition: Spondylodiscitis
Intervention: Other: Cytokine Profile
17 Recruiting Clinical Evaluation of Daptomycin Bone Penetration
Condition: Bone and Joint Infections
Intervention:
18 Recruiting Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers
Condition: Spondylitis, Ankylosing
Intervention: Drug: Etanercept ® 50 mg
19 Not yet recruiting Efficacy and Safety Study of SUNPG1622
Condition: Active Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis
Interventions: Drug: SUNPG1622 I dose;   Drug: Placebo dose
20 Recruiting A Multicenter Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Other: Placebo;   Drug: Bimekizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.